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Abstract: Introduction A new coronavirus, called Severe Acute Respiratory Syndrome-CoronaVirus-2
(SARS-CoV-2), has emerged from China in late 2019 and has now caused a worldwide pandemic. The
impact of covid-19 has not been described so far in a military setting. We therefore report a case series
of infected patients in a recruit school in Switzerland and the herein associated challenges. Material and
methods Retrospective review of covid-19 cases among Swiss Armed Forces recruits in the early weeks of
SARS-CoV-2 pandemic in the canton of Ticino, the southernmost canton of Switzerland. Positive cases
were defined with two positive PCR testing for SARS-CoV-2 from nasopharyngeal swabs. Serological
testing was performed with a commercially available kit according to manufacturers’ instructions. Results
The first case was likely contaminated while skiing during weekend permission. He became symptomatic
4 days later, tested positive for SARS-CoV-2 and was put into isolation. He showed complete symptom
resolution after 48 hours. Quarantine was ordered for all recruits with close contact in the past 2 days, a
total of 55 persons out of 140 in the company. Seven out of nine recruits in one particular quarantine room
became mildly symptomatic. SARS-CoV-2 PCR was positive in one of them. Seven days after initial
diagnosis, the index patient and the other one from the quarantine retested positive for SARS-CoV-2,
although they had been completely asymptomatic for over 96 hours. Serological testing revealed positive
for both patients. All others showed negative IgM and IgG. Conclusions Young healthy recruits often
showed a mild course of covid-19 with rapid symptom decline but were persistent SARS-CoV-2 carriers.
This illustrates how asymptomatic patients may be responsible for covert viral transmission. An early
and prolonged establishment of isolation and quarantine for patients and close contacts is essential to
slow down the spread of SARS-CoV-2, especially in the confined space of a military environment.
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Key messages
 ► Basic hygiene measures and social distancing 
are essential but may be hardly feasible in a 
military setting.
 ► Young patients usually show mild course with 
early symptoms resolution and may be before 
and after symptoms presentation covert carriers 
and spreaders of SARS- CoV-2.
 ► For these reasons, it is important to proceed 
to early prolonged isolation and quarantine 
of patients with covid-19 patients and close 
contacts, respectively.
 ► Covert viral transmission is very likely and may 
explain actual difficulties to contain covid-19 
pandemic
ABSTRACT
Introduction A new coronavirus, called Severe Acute 
Respiratory Syndrome- CoronaVirus-2 (SARS- CoV-2), has 
emerged from China in late 2019 and has now caused 
a worldwide pandemic. The impact of covid-19 has not 
been described so far in a military setting. We therefore 
report a case series of infected patients in a recruit school 
in Switzerland and the herein associated challenges.
Material and methods Retrospective review of 
covid-19 cases among Swiss Armed Forces recruits in the 
early weeks of SARS- CoV-2 pandemic in the canton of 
Ticino, the southernmost canton of Switzerland. Positive 
cases were defined with two positive PCR testing for 
SARS- CoV-2 from nasopharyngeal swabs. Serological 
testing was performed with a commercially available kit 
according to manufacturers’ instructions.
Results The first case was likely contaminated while 
skiing during weekend permission. He became sympto-
matic 4 days later, tested positive for SARS- CoV-2 and was 
put into isolation. He showed complete symptom resolu-
tion after 48 hours. Quarantine was ordered for all recruits 
with close contact in the past 2 days, a total of 55 persons 
out of 140 in the company. Seven out of nine recruits 
in one particular quarantine room became mildly symp-
tomatic. SARS- CoV-2 PCR was positive in one of them. 
Seven days after initial diagnosis, the index patient and 
the other one from the quarantine retested positive for 
SARS- CoV-2, although they had been completely asymp-
tomatic for over 96 hours. Serological testing revealed 
positive for both patients. All others showed negative IgM 
and IgG.
Conclusions Young healthy recruits often showed a 
mild course of covid-19 with rapid symptom decline but 
were persistent SARS- CoV-2 carriers. This illustrates how 
asymptomatic patients may be responsible for covert viral 
transmission. An early and prolonged establishment of 
isolation and quarantine for patients and close contacts is 
essential to slow down the spread of SARS- CoV-2, espe-
cially in the confined space of a military environment.
INTRODUCTION
A new coronavirus causing severe acute respiratory 
syndrome, called SARS- CoV-2,1 emerged in the 
region of Wuhan, Mainland China, in December 
2019.2 This rapidly spreading virus most likely 
originated from bat to human transmission in a 
wet market in China and now caused a worldwide 
pandemic of coronavirus disease (covid-19).3 Cheng 
et al4 already recognised and warned in 2007 about 
the potential time bomb that large reservoirs of 
SARS- CoV- like viruses in horseshoe bats represent.
Exceptional measures have been undertaken by 
the WHO and national governments all over the 
world in an effort to slow the spreading of the 
disease.5 Severe disease occurring in elderly and 
morbid population caused massive overwhelming 
of intensive care units and respiratory support 
teams.6 7
Here, we describe early experience in a military 
setting in Switzerland and the herein associated 
challenges. The cases occurred in the canton of 
Ticino, which is the southernmost canton of Swit-
zerland and borders Italy’s regions of Piedmont 
and Lombardy, which are among the most heavily 
struck covid-19 regions in the world.7 Although 
severe disease is unlikely in the highly selected 
population of a recruit school,8 management of 
logistical issues in this closed environment is highly 
challenging. Our aim is to emphasise how aggres-
sive early management of disease can avoid general 
spread among the troops, which can jeopardise any 
subsidiary engagement in supporting civil institu-
tions and hospitals.
METHODS
This is a retrospective cases series among members of 
the Swiss Armed Forces (MAF) during the covid-19 
pandemic. All members of the Swiss Armed Forces 
provided informed consent for the study.
Nasopharyngeal swabs from both nostrils was 
performed by an experienced otolaryngologist. 
Diagnosis of covid-19 was made after positive PCR 
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Figure 1 Tents inside a military gym to provide extra quarantine/
isolation facilities. The separate tables are for catering.
Figure 2 Sleeping beds inside a military tent shown in Figure 1.
Quarantine was established for persons with close contact 
(less than 2 m) for more than 15 min in the last 48 hours before 
onset symptom of the covid-19 positive index patient.
For serological testing, we used a commercially available 
immunochromatography rapid test with SARS- CoV-2 protein- 
specific IgM and IgG. This test was performed according to the 
manufacturers’ instructions with a reported sensitivity and spec-
ificity of 93% and 95%, respectively.
RESULTS
On 12 March 2020, a recruit presented at the military medical 
centre of Monte Ceneri (Ticino, Switzerland) with headache, 
dry cough and fever since the previous day. His exposition and 
travel history were unremarkable, expect for a skiing trip in 
the Swiss Alps during a permission 4 days before. The patient 
(patient 1) was isolated. PCR testing from nasopharyngeal swab 
was positive for SARS- CoV-2, at the time it was the second posi-
tive case in the Swiss Armed Forces. The patient was treated 
symptomatically with acetaminophen and antitussive drugs. 
Quarantine was ordered for any person with a close contact 
with patient 1. A total of 55 MAFs had to be quarantined, for 
a total headcount of 140 of the concerned company. A sepa-
rate military barrack was requisitioned for the planned quaran-
tine period of 5 days. The 55 MAFs were put in seven separate 
rooms. A thermometer was provided to each room, and a room 
deputy was responsible of reporting the health state of the 
roommates twice a day.
In the first day of the quarantine (13 March 2020), 7 of 9 
MAFs in a particular single room developed flu- like symptoms 
such as coughing, odynophagia, weakness and slightly elevated 
temperatures. PCR nasopharyngeal swabs were negative for all 
cases. Most of the symptomatic quarantined MAFs showed rapid 
resolution of the symptoms without treatment, except for two of 
them. They showed persistent mild cough and slightly elevated 
temperatures.
Nasopharyngeal swab was repeated on 17 March 2020 in 
these two patients. One was positive for covid-19 (patient 2). 
Isolation of the entire room was ordered for 10 more days. The 
MAF in the other rooms did not show any symptoms, and quar-
antine could be withheld after 120 hours.
Both SARS- CoV-2 positive cases (patients 1 and 2) showed 
a very mild disease. Patient 1 had fever for 2 days (38.8°C and 
38.1°C). Patient 2 never developed fever. After 2 days in patient 
1 and 3 days in patient 2, symptoms of covid-19 disappeared 
completely. After 2 and 3 days, symptoms of covid-19 disap-
peared completely in patient 1 and 2, respectively.
Seven days after initial diagnosis (20 March), we repeated 
PCR testing of nasopharyngeal swabs. Both patient 1 and patient 
2 were still positive, although they had been completely asymp-
tomatic and well for the past 5 and 4 days, respectively.
Interestingly, patient 2 had very limited direct contact to 
patient 1, but they both had contact to a third person, which 
remained asymptomatic the whole course of the quarantine and 
tested negative for SARS- CoV-2. Although remaining unproven, 
the third person was likely an asymptomatic SARS- CoV-2 
carrier. This patient may have been the link with patients 1 and 
2.
Finally, we performed serological test on isolated MAF 14 days 
after patient 1 was diagnosed with covid-19. In patients 1 and 2, 
serological testing was positive for both IgM and IgG. Interest-
ingly, all other close contacts to our positive patients, including 
the third suspected asymptomatic carrier, tested negative.
DISCUSSION
Covid-19 epidemic is a rapidly spreading disease that is met with 
exceptional sanitary measures worldwide to limit its spread. As 
illustrated in our case series, limiting the spread of the disease 
has proven to be highly challenging for several reasons.
First, hygiene measures such as hand washing, social distancing 
and sneezing and/or coughing in the elbow are basic measures 
that only show limited efficacy. In the particular conditions of a 
recruit school and military barracks, some of these measures are 
hardly feasible and impractical.
Strict contact isolation is required. It has been shown that 
viable SARS- CoV-2 on plastic surfaces can be present up to 
72 hours after inoculation in experimental setting,9 making 
contagion through door knobs and scale ramps very likely.9 It is 
therefore paramount to ensure separate catering, sanitation and 
lodging. With increasing case and suspected numbers (patients 
with SARS- CoV-2 and quarantined MAFs), it can become 
increasingly difficult to obtain appropriate facilities in a military 
environment. As emergency solution, we used tents to extend 
lodging capacity for quarantined MAFs (Figures 1–3).
Our series shall emphasise the psychological burden during 
the time of quarantine and isolation.10 Although in the military 























































































































3Baettig SJ, et al. BMJ Mil Health 2020;0:1–4. doi:10.1136/bmjmilitary-2020-001482
Original research
Figure 3 Military barracks after days of quarantine and before 
sanitisation.
for logistical reasons, which resulted in although isolated yet not 
lonely quarantine conditions.
Second, many young people are largely asymptomatic but may 
be SARS- CoV-2 carriers transmitting the disease.11 Estimates 
reach from 18% to at least 59% in some studies.12 13 Although 
fever and cough are described as the most common symptoms 
and sometimes deemed to be typical of covid-19,14 it is very 
important to remember that in young adults, symptomatology 
can be much milder and quite atypical. Our two patients showed 
a mild course disease with symptom resolution after few days 
but continued to be positive for SARS- CoV-2 in nasopharyn-
geal swabs. This finding underlies the importance of prolonged 
isolation to reduce further virus transmission, as SARS- CoV-2 
can still be proven in apparently healthy adults many days after 
symptom resolution.15 This is also paramount for health workers 
to not underestimate as, if they became infected, the risk of 
further spreading the disease, while willing to treat it, is high.15
Covert virus spreading also seems to occur during the preclin-
ical inoculation period. Mean incubation time was reported to 
be 6.2 days (range 2–14) with asymptomatic carriers before and 
after the clinical overt phase, if any present.16 In the preclinical 
phase, it is important to separate any person with contact to 
a suspected or confirmed case. On 20 March 2020, the Swiss 
Government increased quarantine time recommendations from 
5 days up to 10 days. Our findings support this decision as it 
covers more accurately the incubation time for contacts.
However, some slightly symptomatic carriers may test nega-
tive in PCR of nasopharyngeal swabs. Therefore, it is important 
to time adequately swabs and to repeat them, if clinical suspicion 
of covid-19 is present. Wang et al17 described the highest sensi-
tivity for PCR for bronchoalveolar lavage fluid (93%) followed 
by sputum (72%), nasal swabs (63%) and pharyngeal swabs 
(32%). A combination of different or symptom- oriented swap 
localisation may be useful.
Of note, SARS- CoV-2 can also be transmitted by oral–faecal 
route with viral shedding proven in stool specimen of patients 
with covid-19.17
The relative lack of sensitivity of PCR, especially in young 
and healthy population, poses great challenges to epidemic 
control.17 18 For that reason, serological testing has gained great 
interest in the past weeks but still requires further validation.19 
In our case series, none of the asymptomatic close contacts to 
patients 1 and 2 tested positive for PCR and/or serology. One 
possible explanation is that hygiene measures during quarantine 
and isolation were sufficient to avoid further spread. However, 
considering the high reproduction number of covid-19, a false- 
negative PCR from nasopharyngeal swab and false negative 
serology have to be considered. For the latter, a weak to mild 
symptomatology could explain the lack of detectable immune 
reaction.20 Finally, negative serological testing might be linked 
to not yet fully validated technology.19 How covert shedding 
of SARS- CoV-2 may be reduced in the future, for example by 
prophylactic hydroxychloroquine,21 remains unknown but is of 
great strategic interest for civil and military authorities.
CONCLUSIONS
Young and healthy patients often show a mild course when 
infected with SARS- CoV-2. They may be before and after 
symptom presentation carriers and spreaders of SARS- CoV-2. 
This factor may lead to significant covert viral transmission.
An early and prolonged establishment of isolation and quar-
antine for patients and close contact persons, respectively, is 
therefore essential to slow down SARS- CoV-2 epidemic growth, 
especially in confined space conditions seen in a military setting.
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